• Explore /
  • Poster
  • / Role of cytoreductive surgery for the second ovarian cancer relapse in patients previously treated with chemotherapy alone at first relapse: A subanalysis of the DESKTOP III trial.

Role of cytoreductive surgery for the second ovarian cancer relapse in patients previously treated with chemotherapy alone at first relapse: A subanalysis of the DESKTOP III trial.

Abstract Poster

Authors

null

Jalid Sehouli

Charité– Medical University of Berlin, Berlin, Germany

Jalid Sehouli , Christina Fotopoulou , Ignace Vergote , Alexander Reuss , Gwenael Ferron , Werner Meier , Stefano Greggi , Berit J. Mosgaard , Frederic Selle , Frederic Guyon , Christophe Pomel , Fabrice Lecuru , Rongyu Zang , Kristina Hellmann , Jae-Weon Kim , Margarita Romeo , Francesco Raspagliesi , Brynhildur Eyjólfsdóttir , Andreas Du Bois , Philipp Harter

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Gynecologic Cancer

Track

Gynecologic Cancer

Sub Track

Ovarian Cancer

Clinical Trial Registration Number

NCT01166737

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 5520)

DOI

10.1200/JCO.2022.40.16_suppl.5520

Abstract #

5520

Poster Bd #

399

Abstract Disclosures

Similar Posters

First Author: Mansoor Raza Mirza

First Author: Inna Y Gong

First Author: Eric Jay Feldman

Poster

2012 ASCO Annual Meeting

The impact of interval cytoreduction and age in advanced-stage ovarian cancer: A GOG ancillary study.

The impact of interval cytoreduction and age in advanced-stage ovarian cancer: A GOG ancillary study.

First Author: Stuart M. Lichtman